| Autor: |
Piccinin CC; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: piccinc@ccf.org., Yu JRT; Institute for Neurosciences, St. Luke's Medical Center, Quezon City and Global City, Philippines; University of the East Ramon Magsaysay Memorial Medical Center, 64 Aurora Boulevard, Quezon City, Philippines. Electronic address: jerylyu@gmail.com., Brooks A; Parkinson's Foundation, 200 SE 1ST street, suite 800, Miami, FL, 33131, USA. Electronic address: abrooks@parkinson.org., Clark P; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: clarkp5@ccf.org., Shaffer S; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: shaffes4@ccf.org., Sokola BS; Department of Pharmacy, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: sokolab@ccf.org., Lewin K; Head and Neck Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44106, USA. Electronic address: klewin@ccf.org., Whitman JP; Center for General Neurology, Cleveland Clinic - Fairview Hospital, 18101 Lorain Ave, Cleveland, OH, 44111, USA. Electronic address: whitmaj2@ccf.org., Sperling SA; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: sperlis@ccg.org., Fernandez HH; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: fernanh@ccf.org., Walter BL; Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA. Electronic address: walterb7@ccf.org. |
| Abstrakt: |
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: HHF has received research support from Biogen, Cerevel, Michael J. Fox Foundation, NIH/NINDS, Parkinson Study Group, Parkinson's Foundation, Roche but has no owner interest in any pharmaceutical company; has received honoraria from, Cleveland Clinic as a speaker in CME events; has received honoraria from Amneal, AbbVie, Cerevel, Neurocrine, Parkinson Study Group as a consultant. Elsevier as the Editor-In-Chief of Parkinsonism and Related Disorders Journal; has received royalty payments from Springer for serving as a book author/editor. BW serves as Section Head of Movement Disorders at the Cleveland Clinic. Over the years, he has received research grants from the NIH and Parkinson's Foundation. He has served as site investigator and/or co-investigator for clinical research studies sponsored by grants from Industry to Cleveland Clinic. Currently, he is the site PI for Neuroderm (Mitsubishi Tanabe Pharma), Discern (Great Lakes Neurotech/NIH R44), Tempo 2, and Tempo 3 studies (Cerevel Therapeutics) and a grant from the Parkinson's Foundation to improve the inpatient care of People with PD. He has served as a consultant or speaker for Medtronic, Boston Scientific, and Abbott for less than $5000 in the last year. |
Full Text from ScienceDirect